Trial Profile
Safety, tolerability, pharmacokinetics and pharmacodynamics of SC denosumab in postmenopausal Japanese women
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 22 Dec 2011 New trial record
- 01 Nov 2011 Results published in Bone.